Immunogenicity and Safety of Booster Immunization of ZF2001 After Inoculation With Two Doses of CoronaVac

NCT05205096 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

480

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

BIOLOGICAL: Recombinant novel coronavirus vaccine (CHO cells)

Sponsor

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.

Collaborators

[object Object]